The results of this analysis demonstrated that, at 24 weeks, only exemestane treatment consistently resulted in an increase in the level of PINP, with a median percentage change of 24% and 95% CI of 11–30% (Table 3 ); however, between-group differences did not reach statistical significance at 24 weeks ( P = 0.147).
← all excerpts
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.
1
0.1470
0.1470